The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the recall of a specific batch of Deekins Amoxycillin 500mg Capsules.
In a statement released on X (formerly Twitter) on Wednesday, NAFDAC identified the affected batch as lot number 4C639001, which was manufactured by Eco-med Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd.
The recall follows reports of serious adverse drug reactions linked to this batch. Eco-med Pharma Ltd confirmed that a hospital had reported three cases of severe reactions in patients who were administered capsules from the batch in question.
The statement reads: “NAFDAC is notifying the public of the recall of one batch of Deekins Amoxycillin 500mg Capsules, manufactured by Eco-med Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd, with lot number 4C639001. This recall follows reports of serious adverse drug reactions.”
Amoxicillin, a penicillin antibiotic, is commonly used to treat bacterial infections such as tonsillitis, bronchitis, sinusitis, pneumonia, and infections of the ear, nose, throat, skin, or urinary tract.
NAFDAC has advised healthcare professionals and consumers to immediately discontinue use of the affected batch. It also urged anyone who suspects the presence of substandard or falsified medicines to report such cases to the nearest NAFDAC office.
“Healthcare professionals and consumers are advised to report any suspicion of substandard and falsified medicines to the nearest NAFDAC office, call 0800-162-3322, or email sf.alert@nafdac.gov.ng,” the statement concluded.
